Lv3
290 积分 2022-04-25 加入
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial
3天前
已完结
Epidemiology of Renal Cell Carcinoma: 2022 Update
6个月前
已完结
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma
6个月前
已完结
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
10个月前
已完结
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection
1年前
已完结
Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies
1年前
已完结
Metabolism and excretion of therapeutic peptides: current industry practices, perspectives, and recommendations
1年前
已完结
雄激素在痤疮发病机制中的作用及治疗应用
1年前
已完结
皖公网安备34019202002308
